|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arnold M, Soerjomataram l, Ferlay J and
Forman D: Global incidence of oesophageal cancer by histological
subtype in 2012. Gut. 64:381–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Murphy G, McCormack V, Abedi-Ardekani B,
Arnold M, Camargo MC, Dar NA, Dawsey SM, Etemadi A, Fitzgerald RC,
Fleischer DE, et al: International cancer seminars: A focus on
esophageal squamous cell carcinoma. Ann Oncol. 28:2086–2093. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu
L and He J: Report of incidence and mortality in China cancer
registries, 2009. Chin J Cancer Res. 25:10–21. 2013.PubMed/NCBI
|
|
5
|
Cheng J, Jin H, Hou X, Lv J, Gao X and
Zheng G: Disturbed tryptophan metabolism correlating to progression
and metastasis of esophageal squamous cell carcinoma. Biochem
Biophys Res Commun. 486:781–787. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bracken CP, Scott HS and Goodall GJ: A
network-biology perspective of microRNA function and dysfunction in
cancer. Nat Rev Genet. 17:719–732. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sakai NS, Samia-Aly E, Barbera M and
Fitzgerald RC: A review of the current understanding and clinical
utility of miRNAs in esophageal cancer. Semin Cancer Biol.
23:512–521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Harada K, Baba Y, Ishimoto T, Shigaki H,
Kosumi K, Yoshida N, Watanabe M and Baba H: The role of microRNA in
esophageal squamous cell carcinoma. J Gastroenterol. 51:520–530.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao BS, Liu SG, Wang TY, Ji YH, Qi B, Tao
YP, Li HC and Wu XN: Screening of microRNA in patients with
esophageal cancer at same tumor node metastasis stage with
different prognoses. Asian Pac J Cancer Prev. 14:139–143. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qi B, Liu SG, Qin XG, Yao WJ, Lu JG, Guo
L, Wang TY, Li HC and Zhao BS: Overregulation of microRNA-212 in
the poor prognosis of esophageal cancer patients. Genet Mol Res.
13:7800–7807. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li B, Li J, Xu WW, Guan XY, Qin XY, Zhang
LY, Law S, Tsao SW and Cheung AL: Suppression of esophageal tumor
growth and chemoresistance by directly targeting the PI3K/Akt
pathway. Oncotarget. 5:11576–11587. 2014.PubMed/NCBI
|
|
13
|
Lu Z, Peng K, Wang N, Liu HM and Hou G:
Downregulation of p70S6K enhances cell sensitivity to rapamycin in
esophageal squamous cell carcinoma. J Immunol Res.
2016:78289162016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Medina EA, Obertheu K, Polusani SR, Ortega
V, Velagaleti GV and Oyajobi BO: PKA/AMPK signaling in relation to
adiponectin's antiproliferative effect on multiple myeloma cells.
Leukemia. 28:2080–2089. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang F, Wang YG and Wang C: Metformin
inhibited growth, invasion and metastasis of esophageal squamous
cell carcinoma in vitro and in vivo. Cell Physiol Biochem.
51:1276–1286. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen YZ, Bai N, Bi JH, Liu XW, Xu Go,
Zhang LF, Li XQ and Huo R: Propranolol inhibits the proliferation,
migration and tube formation of hemangioma cells through HIF-1α
dependent mechanisms. Braz J Med Biol Res. 50:e61382017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang SX, Qi B, Yao WJ, Gu CW, Wei XF,
Zhao Y, Liu YZ and Zhao BS: Berberine displays antitumor activity
in esophageal cancer cells in vitro. World J Gastroenterol.
23:2511–2518. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Method. 5:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial- mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baker EA, Stephenson TJ, Reed MW and Brown
NJ: Expression of proteinases and inhibitors in human breast cancer
progression and survival. Mol Pathol. 55:300–304. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rao JS, Gondi C, Chetty C, Chittivelu S,
Joseph PA and Lakka SS: Inhibition of invasion, angiogenesis, tumor
growth and metastasis by adenovirus-mediated transfer of antisense
uPAR and MMP-9 in non-small cell lung cancer cells. Mol Cancer
Ther. 4:1399–1408. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang YY, Tang LQ and Wei W: Berberine
attenuates podocytes injury caused by exosomes derived from high
glucose-induced mesangial cells through TGFβ1-PI3K/AKT pathway. Eur
J Pharmacol. 824:185–192. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mishan MA, Ahmadiankia N, Matin MM,
Heirani-Tabasi A, Shahriyari M, Bidkhori HR, Naderi-Meshkin H and
Bahrami AR: Role of berberine on molecular markers involved in
migration of esophageal cancer cells. Cell Mol Biol
(Noisy-le-grand). 61:37–43. 2015.PubMed/NCBI
|
|
24
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Remenyi J, vanden Bosch MW, Palygin O,
Mistry RB, McKenzie C, Macdonald A, Hutvagner G, Arthur JS,
Frenguelli BG and Pankratov Y: miR-132/212 Knockout mice reveal
roles for these miRNAs in regulating cortical synaptic transmission
and plasticity. PLoS One. 8:e625092013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Remenyi J, Hunter CJ, Cole C, Ando H,
Impey S, Monk CE, Martin KJ, Barton GJ, Hutvagner G and Arthur JS:
Regulation of the miR-212/132 locus by MSK1 and CREB in response to
neurotrophins. Biochem J. 428:281–291. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiping Z, Ming F, Lixiang W, Xiuming L,
Yuqun S, Han Y, Zhifang L, Yundong S, Shili L, Chunyan C and Jihui
J: MicroRNA-212 inhibits proliferation of gastric cancer by
directly repressing retinoblastoma binding protein 2. J Cell
Biochem. 114:2666–2272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Roomi MW, Kalinovsky T, Niedzwiecki A and
Rath M: Modulation of uPA, MMPs and their inhibitors by a novel
nutrient mixture in human colorectal, pancreatic and hepatic
carcinoma cell lines. Int J Oncol. 47:370–376. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yamashita K, Tanaka Y, Mimori K, Inoue H
and Mori M: Differential expression of MMP and uPA systems and
prognostic relevance of their expression in esophageal squamous
cell carcinoma. Int J Cancer. 110:201–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yan C and Boyd DD: Regulation of matrix
metalloproteinase gene expression. J Cell physiol. 211:19–26. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chakraborti S, Mandal M, Das S, Mandal A
and Chakraborti T: Regulation of matrix metalloproteinases: An
overview. Mol Cell Biochem. 253:269–285. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kou Y, Li L, Li H, Tan Y, Li B, Wang K and
Du B: Berberine suppressed epithelial mesenchymal transition
through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma
cells. Biochem Biophys Res Commun. 479:290–296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li L, Wang X, Sharvan R, Gao J and Qu S:
Berberine could inhibit thyroid carcinoma cells by inducing
mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing
migration via PI3K-AKT and MAPK signaling pathways. Biomed
Pharmacother. 95:1225–1231. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ai F, Chen M, Yu B, Yang Y, Xu G, Gui F,
Liu Z, Bai X and Chen Z: Berberine regulates proliferation,
collagen synthesis and cytokine secretion of cardiac fibroblasts
via AMPK-mTOR-p70S6K signaling pathway. Int J Clin Exp Pathol.
8:12509–12516. 2015.PubMed/NCBI
|
|
35
|
Kim HS, Kim MJ, Kim EJ, Yang Y, Lee MS and
Lim JS: Berberine-induced AMPK activation inhibits the metastatic
potential of melanoma cells via reduction of ERK activity and COX-2
protein expression. Biochem Pharmacol. 83:385–394. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xie M, Fu Z, Cao J, Liu Y, Wu J, Li Q and
Chen Y: MicroRNA-132 and microRNA-212 mediate doxorubicin
resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway
in breast cancer. Biomed Pharmacother. 102:286–294. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fu W, Tao T, Qi M, Wang L, Hu J, Li X,
Xing N, Du R and Han B: MicroRNA-132/212 upregulation inhibits
TGF-β-mediated epithelial-mesenchymal transition of prostate cancer
cells by targeting SOX4. Prostate. 76:1560–1570. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ma C, Nong K, Wu B, Dong B, Bai Y, Zhu H,
Wang W, Huang X, Yuan Z and Ai K: miR-212 promotes pancreatic
cancer cell growth and invasion by targeting the hedgehog signaling
pathway receptor patched-1. J Exp Clin Cancer Res. 33:542014.
View Article : Google Scholar : PubMed/NCBI
|
